Proteor
Entry
2025
Hold
1yr
Status
Active
Who owns Proteor?
Proteor is currently owned by Eurazeo through Nov Sante Actions Non Cotees (2020 vintage), since 2025. Across its history, Proteor has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
EurazeoNov Sante Actions Non Cotees · 2020 · Healthcare
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by BNP Paribas Developpement, Crédit Mutuel Equity and Eurazeo since 2025.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2025 · present
EurazeoActive
2025 · present(1yr) · Nov Sante Actions Non Cotees · 2020 · Healthcare
Crédit Mutuel EquityActive
2025 · present(1yr) · Crédit Mutuel Equity · 1992 · Growth
More from Nov Sante Actions Non Cotees
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Optos
Exited 2015
Amadeus Capital Partners
UK
UKto
Axomove
Active
Go Capital
France· 2026
France· 2026Bioliberty
Active
Scottish National Investment BankUK· 2026
UK· 2026CertHub
Active
Cusp Capital Partners
Germany· 2026
Germany· 2026Clee Medical
Active
High-Tech Gruenderfonds (HTGF)
Switzerland· 2026
Switzerland· 2026CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Germany· 2026Track Proteor
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Proteor.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue